Pancragen Peptide

Pancreatic tetrapeptide that normalizes beta-cell gene expression and insulin secretion patterns. Research shows restored glucose-stimulated insulin secretion, improved islet cell survival, and normalized HbA1c in diabetic models.

Pancragen (Lys-Glu-Asp-Trp, KEDW) is a short synthetic peptide bioregulator developed within the framework of peptide bioregulation theory advanced at the St. Petersburg Institute of Bioregulation and Gerontology. Mechanistic investigations indicate that KEDW exerts its effects primarily through tissue-specific epigenetic modulation of gene expression in pancreatic cells, particularly in the endocrine islet cells responsible for insulin and glucagon secretion.

Epigenetic and Transcriptional Regulation

Research in isolated pancreatic cell cultures suggests that Pancragen can penetrate the cytoplasmic and nuclear membranes and bind directly to histone proteins and specific promoter regions of DNA. Khavinson and colleagues have proposed that KEDW selectively interacts with CpG-rich promoter sequences of genes such as PDX1, NGN3, FOXA2, PAX6, and NKX2-2 — transcription factors central to pancreatic endocrine cell differentiation and maintenance of the beta-cell phenotype. Activation of these regulatory networks has been associated with increased expression of insulin (INS) and glucagon (GCG) genes in cultured cells derived from young and aged donors.

Restoration of Beta-Cell Functional Activity

In long-term cultures of pancreatic cells, repeated exposure to KEDW has been reported to restore declining synthetic activity characteristic of senescent cultures. This is thought to occur via re-expression of pluripotency- and differentiation-related markers, including PDX-1, which orchestrates beta-cell identity and insulin gene transcription. Increases in PDX-1 expression in aged cell cultures following KEDW exposure have been documented at 1.5- to 2-fold over untreated controls in published preclinical reports.

Telomere and Proliferative Capacity Effects

Pancragen has been investigated as part of a broader family of Khavinson tetrapeptides whose interaction with telomere-associated chromatin may extend proliferative capacity of somatic cells. In pancreatic islet preparations, KEDW exposure has been associated with prolonged maintenance of mitotic activity and reduced expression of senescence markers such as p16^INK4a, though these findings remain preclinical and are limited to ex vivo systems.

Downstream Metabolic Signaling

By upregulating beta-cell transcription factors, Pancragen indirectly modulates insulin biosynthesis and secretion machinery, including SUR1/Kir6.2 K-ATP channels and the glucokinase glucose-sensing pathway. Research models suggest that restored PDX-1 activity also enhances GLUT2 expression and amplifies glucose-stimulated insulin secretion (GSIS). Parallel effects on alpha-cell transcription factors (e.g., ARX, MAFB) have been suggested to normalize glucagon output, contributing to balanced pancreatic islet hormone signaling in research models of impaired glucose tolerance.

Comparison to Related Bioregulators

Whereas Epithalon (Ala-Glu-Asp-Gly) is associated with pineal/telomerase activity and Vilon (Lys-Glu) with thymic immune function, Pancragen shows tissue selectivity for pancreatic cell lineages. This selectivity is hypothesized to arise from the unique combination of the basic Lys, acidic Glu/Asp, and aromatic Trp residues, which produces a charge–hydrophobicity profile complementary to pancreas-specific promoter regions.

Pancragen is a short tetrapeptide bioregulator with well-defined physicochemical properties suitable for handling in standard laboratory environments. Its small size and high water solubility make it a convenient compound for cell culture and biochemical research applications. Verified specifications are provided below.

The small molecular weight (559.57 g/mol) places Pancragen among the smallest peptide bioregulators studied, comparable in size to Vilon (Lys-Glu, dipeptide) and Epithalon (Ala-Glu-Asp-Gly, tetrapeptide). Its compact structure facilitates intracellular and nuclear penetration without the need for delivery carriers, a property emphasized in mechanistic investigations of Khavinson tetrapeptides. The presence of tryptophan provides a UV-detectable chromophore (absorbance maximum ~280 nm), which is useful for HPLC quantification and stability assessment in research workflows.

Pancragen (KEDW tetrapeptide) is supplied as a lyophilized white powder intended exclusively for laboratory research. As a short hydrophilic tetrapeptide containing tryptophan, it requires careful handling to preserve structural integrity and prevent oxidative degradation of the indole side chain.

Reconstitution Protocol

1. Allow the sealed vial to equilibrate to room temperature (approximately 15-20 minutes) before opening. This minimizes condensation on the lyophilized cake when the seal is breached.
2. Select an appropriate reconstitution solvent. Bacteriostatic water (0.9% benzyl alcohol) or sterile water for injection is suitable. For mass spectrometry or HPLC analysis, use LC-MS grade water or 0.1% acetic acid.
3. Calculate desired working concentration. For a 20 mg vial reconstituted with 2 mL of solvent, the resulting concentration is 10 mg/mL. For a 5 mg/mL working solution, add 4 mL of solvent.
4. Inject the solvent slowly down the inner wall of the vial. Do not direct the stream onto the peptide cake, as this can cause foaming and partial denaturation.
5. Gently swirl the vial in a circular motion until the powder is fully dissolved. Do not shake or vortex vigorously — mechanical agitation can induce aggregation and oxidation.
6. Inspect the solution. A properly reconstituted KEDW solution should be clear and colorless. Any persistent cloudiness or particulates indicate compromised material.
7. Aliquot into low-binding polypropylene tubes if multiple research uses are anticipated, to minimize freeze-thaw cycles.

Compound-Specific Notes

The C-terminal tryptophan residue is susceptible to oxidation, particularly under exposure to light, heat, or trace metal contamination. Work under reduced light conditions where feasible and avoid contact with copper or iron surfaces. The peptide is highly water-soluble due to the charged Lys and Glu/Asp residues, and DMSO is generally not required. Acidic conditions (pH 3-5) enhance solubility and stability for short-term in vitro assays.

Proper storage of Pancragen (KEDW) is critical for maintaining peptide integrity, particularly given the tryptophan-mediated oxidative sensitivity of the sequence. Recommended storage conditions vary based on whether the peptide is in lyophilized or reconstituted form.

Lyophilized Powder

• Long-term storage: -20°C or colder in the original sealed vial with desiccant. Under these conditions, lyophilized KEDW is stable for 24-36 months without measurable degradation by HPLC.
• Short-term storage: 2-8°C is acceptable for periods up to 30 days, provided the vial remains sealed and protected from moisture.
• Transit / ambient: Brief exposure to room temperature (up to 7 days) during shipping does not significantly compromise integrity of the lyophilized form, owing to the inherent stability of dry peptide powders.

Reconstituted Solution

• 2-8°C (refrigerated): Reconstituted KEDW in sterile or bacteriostatic water is stable for approximately 14-21 days. Concentrations of 1-10 mg/mL show optimal stability in this range.
• -20°C (frozen aliquots): Single-use aliquots stored at -20°C in low-binding polypropylene tubes retain potency for 60-90 days. Avoid repeated freeze-thaw cycles, which accelerate aggregation and tryptophan oxidation.
• Room temperature: Not recommended for reconstituted solutions beyond 24 hours.

Stability Considerations

The KEDW sequence does not contain cysteine residues, eliminating concerns about disulfide scrambling. However, the indole ring of tryptophan can undergo photooxidation to N-formylkynurenine and kynurenine under prolonged UV exposure. Storage in amber vials or wrapped in foil is advised for extended studies. Repeated thermal cycling should be avoided, and aliquoting at the time of initial reconstitution is recommended best practice to preserve assay reproducibility across long-term research protocols.